X-41447611-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_022567.3(NYX):c.-294T>C variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.345 in 389,488 control chromosomes in the GnomAD database, including 16,741 homozygotes. There are 43,412 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.29 ( 3731 hom., 10039 hem., cov: 23)
Exomes 𝑓: 0.37 ( 13010 hom. 33373 hem. )
Consequence
NYX
NM_022567.3 5_prime_UTR_premature_start_codon_gain
NM_022567.3 5_prime_UTR_premature_start_codon_gain
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.937
Genes affected
NYX (HGNC:8082): (nyctalopin) The product of this gene belongs to the small leucine-rich proteoglycan (SLRP) family of proteins. Defects in this gene are the cause of congenital stationary night blindness type 1 (CSNB1), also called X-linked congenital stationary night blindness (XLCSNB). CSNB1 is a rare inherited retinal disorder characterized by impaired scotopic vision, myopia, hyperopia, nystagmus and reduced visual acuity. The role of other SLRP proteins suggests that mutations in this gene disrupt developing retinal interconnections involving the ON-bipolar cells, leading to the visual losses seen in patients with complete CSNB. [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant X-41447611-T-C is Benign according to our data. Variant chrX-41447611-T-C is described in ClinVar as [Benign]. Clinvar id is 368266.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.569 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NYX | NM_001378477.3 | c.-57+95T>C | intron_variant | ENST00000378220.3 | NP_001365406.2 | |||
NYX | NM_022567.3 | c.-294T>C | 5_prime_UTR_premature_start_codon_gain_variant | 1/2 | NP_072089.2 | |||
NYX | NM_022567.3 | c.-294T>C | 5_prime_UTR_variant | 1/2 | NP_072089.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NYX | ENST00000342595 | c.-294T>C | 5_prime_UTR_premature_start_codon_gain_variant | 1/2 | 1 | ENSP00000340328.3 | ||||
NYX | ENST00000342595 | c.-294T>C | 5_prime_UTR_variant | 1/2 | 1 | ENSP00000340328.3 | ||||
NYX | ENST00000378220.3 | c.-57+95T>C | intron_variant | 1 | NM_001378477.3 | ENSP00000367465.2 |
Frequencies
GnomAD3 genomes AF: 0.293 AC: 32473AN: 110680Hom.: 3730 Cov.: 23 AF XY: 0.304 AC XY: 10011AN XY: 32956
GnomAD3 genomes
AF:
AC:
32473
AN:
110680
Hom.:
Cov.:
23
AF XY:
AC XY:
10011
AN XY:
32956
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.366 AC: 101933AN: 278751Hom.: 13010 Cov.: 0 AF XY: 0.396 AC XY: 33373AN XY: 84361
GnomAD4 exome
AF:
AC:
101933
AN:
278751
Hom.:
Cov.:
0
AF XY:
AC XY:
33373
AN XY:
84361
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.293 AC: 32496AN: 110737Hom.: 3731 Cov.: 23 AF XY: 0.304 AC XY: 10039AN XY: 33021
GnomAD4 genome
AF:
AC:
32496
AN:
110737
Hom.:
Cov.:
23
AF XY:
AC XY:
10039
AN XY:
33021
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 12, 2018 | - - |
Congenital stationary night blindness 1A Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at